TrialBMC cancer2022

Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution.

Toshihiko Masui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.